Lewis-Hall Freda C

Executive Vice President at PFE; EVP, Medicines Development at VRTX

Sold, on record
$1.2M
Dollars the filings state
Form 4 sales
4
Latest Sep 16, 2013
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • PFEPFIZER INCExecutive Vice President
  • VRTXVERTEX PHARMACEUTICALS INC / MAEVP, Medicines Development

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale VRTXPlan not stated
    Dec 11, 2008 2008

    Sold 1,250 shares at $26.00 ($33k)

    Lewis-Hall Freda C, EVP, Medicines Development

    Sold 2.8% of holdings ($1.2M position)43,750 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale VRTXPlan not stated
    Dec 19, 2008 +8 days

    Sold 1,250 shares at $29.90 ($37k)

    Lewis-Hall Freda C, EVP, Medicines Development

    Sold 2.9% of holdings ($1.3M position)42,500 shares leftFiling

  3. 3 Form 4 sale VRTXPlan not stated
    Mar 19, 2009 +90 days

    Sold 1,250 shares at $29.11 ($36k)

    Lewis-Hall Freda C, EVP, Medicines Development

    Sold 2.3% of holdings ($1.6M position)53,334 shares leftFiling

  4. 4 Form 4 sale PFEPlan not stated
    Sep 16, 2013 +1642 days

    Sold 38,461 shares at $28.70 ($1.1M)

    Lewis-Hall Freda C, Executive Vice President

    Sold 24.5% of holdings ($4.5M position)118,383 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Lewis-Hall Freda C
Source
Sep 16, 2013Sep 18, 2013PFEExecutive Vice PresidentForm 4 sale38,461$1.1M24.5%Plan not statedSEC
Mar 19, 2009Mar 20, 2009VRTXEVP, Medicines DevelopmentForm 4 sale1,250$36k2.3%Plan not statedSEC
Dec 19, 2008Dec 22, 2008VRTXEVP, Medicines DevelopmentForm 4 sale1,250$37k2.9%Plan not statedSEC
Dec 11, 2008Dec 12, 2008VRTXEVP, Medicines DevelopmentForm 4 sale1,250$33k2.8%Plan not statedSEC